Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
If your appetite is stronger, you can add more
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
GLP-1R positive nerve fibres (Abcam antibody, left panels) and PGP9.5 (right panels) in mucosal sigmoid colon biopsy specimens, from topcontrol, middle and bottomIBD, magnification x40
Compared to a placebo (a fake drug with no therapeutic effect), all doses of both drugs had an increased risk for gastrointestinal issues
US$ 26.25
US$ 29.42
US$ 23.02
US$ 21.26
